{"EPA_reg_num": "6836-277", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "BARDAC 205M-1.30", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 10.0, "Formulation_type": "[\"Dilutable\", \"Electrostatic Spray\"]", "Follow_directions_for_this_virus": "Norovirus", "Date_on_List_N": "2020-03-13", "Why_on_List_N": "Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1438}
{"EPA_reg_num": "6836-303", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "BARDAC 205M-5.2", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 10.0, "Formulation_type": "[\"Dilutable\", \"Electrostatic Spray\"]", "Follow_directions_for_this_virus": "Norovirus", "Date_on_List_N": "2020-03-13", "Why_on_List_N": "Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1439}
{"EPA_reg_num": "6836-266", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "BARDAC 205M-10", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 10.0, "Formulation_type": "[\"Dilutable\", \"Electrostatic Spray\"]", "Follow_directions_for_this_virus": "Norovirus", "Date_on_List_N": "2020-03-03", "Why_on_List_N": "Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1478}
{"EPA_reg_num": "6836-278", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "BARDAC 205M- 14.08", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 10.0, "Formulation_type": "[\"Dilutable\", \"Electrostatic Spray\"]", "Follow_directions_for_this_virus": "Norovirus", "Date_on_List_N": "2020-03-03", "Why_on_List_N": "Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1479}
{"EPA_reg_num": "6836-302", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "BARDAC 205M-2.6", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 10.0, "Formulation_type": "[\"Dilutable\", \"Electrostatic Spray\"]", "Follow_directions_for_this_virus": "Norovirus", "Date_on_List_N": "2020-03-03", "Why_on_List_N": "Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1481}
{"EPA_reg_num": "6836-305", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "BARDAC 205M-23", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 10.0, "Formulation_type": "[\"Dilutable\", \"Electrostatic Spray\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2020-03-03", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1482}
{"EPA_reg_num": "6836-70", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "BARDAC 205M-7.5", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 10.0, "Formulation_type": "[\"Dilutable\", \"Electrostatic Spray\"]", "Follow_directions_for_this_virus": "Norovirus", "Date_on_List_N": "2020-03-03", "Why_on_List_N": "Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1486}
{"EPA_reg_num": "71847-6", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Sodium dichloroisocyanurate\"]", "Product_name": "Klorsept", "Company": "Medentech LTD", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\", \"Electrostatic Spray\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-01-28", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1493}
{"EPA_reg_num": "71847-7", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Sodium dichloroisocyanurate\"]", "Product_name": "Klorkleen", "Company": "Medentech LTD", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 4.0, "Formulation_type": "[\"Dilutable\", \"Electrostatic Spray\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-01-28", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1494}